APPLICATION
ANDA076962
TYPE
ANDA
ORIGINAL APPROVAL
2004-09-24
LATEST ACTION
2020-08-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
BROMOCRIPTINE MESYLATEDiscontinued
BROMOCRIPTINE MESYLATE EQ 2.5MG BASE · TABLET · ORAL
Approval history
2020-08-21Labeling · Supplement 10 · standardAP
2015-02-13Labeling · Supplement 7 · standardAP
2006-08-15Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.